Hypertension — bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
Citation(s)
Aardex Group (n.d.). MEMS® Button Medication Event Monitoring System. https://aardexgroup.com/about-us/
Al-Saleh, S , Lee, J. K., Rogers, W. A., & Insel, K. C. (2022). Translation of a Successful Behavioral Intervention to a Digital Therapeutic Self-Management System for Older Adults. Ergonomics in Design, 10648046211066408. https://doi.org/10.1177/10648046211066409
Brooke, J (1996). SUS: A quick and dirty usability scale. Usability Evaluation in Industry, 189, 4-7.
Chan AHY, Horne R, Hankins M, Chisari C The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence. Br J Clin Pharmacol. 2020 Jul;86(7):1281-1288. doi: 10.1111/bcp.14193. Epub 2020 May 18.
Erkoc SB, Isikli B, Metintas S, Kalyoncu C Hypertension Knowledge-Level Scale (HK-LS): a study on development, validity and reliability. Int J Environ Res Public Health. 2012 Mar;9(3):1018-29. doi: 10.3390/ijerph9031018. Epub 2012 Mar 22.
Masterson Creber RM, Maurer MS, Reading M, Hiraldo G, Hickey KT, Iribarren S Review and Analysis of Existing Mobile Phone Apps to Support Heart Failure Symptom Monitoring and Self-Care Management Using the Mobile Application Rating Scale (MARS). JMIR Mhealth Uhealth. 2016 Jun 14;4(2):e74. doi: 10.2196/mhealth.5882.
Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
